Timo Schomann

922 total citations
35 papers, 722 citations indexed

About

Timo Schomann is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Timo Schomann has authored 35 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Biomedical Engineering and 9 papers in Immunology. Recurrent topics in Timo Schomann's work include Nanoplatforms for cancer theranostics (9 papers), Photoacoustic and Ultrasonic Imaging (5 papers) and Immune cells in cancer (5 papers). Timo Schomann is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Photoacoustic and Ultrasonic Imaging (5 papers) and Immune cells in cancer (5 papers). Timo Schomann collaborates with scholars based in Netherlands, Brazil and Germany. Timo Schomann's co-authors include Luis J. Cruz, Alan Chan, Raimundo Fernandes de Araújo Júnior, Hao Yang, Zili Gu, Ferry Ossendorp, Christina Eich, Peter ten Dijke, Barbara Kaltschmidt and Darius Widera and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Controlled Release.

In The Last Decade

Timo Schomann

34 papers receiving 714 citations

Peers

Countries citing papers authored by Timo Schomann

Since Specialization

Citations

This map shows the geographic impact of Timo Schomann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Schomann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Schomann more than expected).

Fields of papers citing papers by Timo Schomann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Schomann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Schomann. The network helps show where Timo Schomann may publish in the future.

Co-authorship network of co-authors of Timo Schomann

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Schomann. A scholar is included among the top collaborators of Timo Schomann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Schomann. Timo Schomann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Poloxamer-based thermosensitive injectable hydrogels containing a self-assembling peptide for In situ gelation 2025 ·Computational and Structural Biotechnology Journal ·(unknown), Timo Schomann, (unknown), (unknown), Y.F. Ramos, Tina Vermonden, Louise van der Weerd, Ingrid Meulenbelt, Luis J. Cruz	0
2	Preclinical evaluation of glycan-targeting monoclonal antibodies for bimodal near-infrared fluorescence and photoacoustic imaging of gastrointestinal cancers 2025 ·EJNMMI Research ·(unknown), (unknown), (unknown), (unknown), Timo Schomann, (unknown), Mireille Vankemmelbeke, Lindy G. Durrant, Daniëlle Krijgsman, Pieter de Heer, (unknown), J. Sven D. Mieog, (unknown), Jacobus Burggraaf, Peter J.K. Kuppen, Alexander L. Vahrmeijer, (unknown)	1
3	Retinoic acid-loaded PLGA nanocarriers targeting cell cholesterol potentialize the antitumour effect of PD-L1 antibody by preventing epithelial-mesenchymal transition mediated by M2-TAM in colorectal cancer 2023 ·Translational Oncology ·Raimundo Fernandes de Araújo Júnior, (unknown), Timo Schomann, (unknown), (unknown), Regina C.M. de Paula, (unknown), Chih Kit Chung, (unknown), (unknown), Alan Chan, Luis J. Cruz	10
4	Dual‐Targeting Nanoliposome Improves Proinflammatory Immunomodulation of the Tumor Microenvironment 2023 ·Advanced Healthcare Materials ·Zili Gu, Candido G. Da Silva, (unknown), Qi Liu, Timo Schomann, Ferry Ossendorp, Luis J. Cruz	6
5	Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), (unknown), (unknown), (unknown), Timo Schomann, Shadhvi S. Bhairosingh, (unknown), (unknown), Gerard J. P. van Westen, Andreas Plückthun, Jacobus Burggraaf, Peter J.K. Kuppen, Alexander L. Vahrmeijer, Cornelis F.M. Sier	8
6	Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation 2023 ·Journal of Controlled Release ·Zili Gu, Hao Yang, Timo Schomann, Ferry Ossendorp, Peter ten Dijke, Luis J. Cruz	64
7	Inhibition of murine colorectal cancer metastasis by targeting M2-TAM through STAT3/NF-kB/AKT signaling using macrophage 1-derived extracellular vesicles loaded with oxaliplatin, retinoic acid, and Libidibia ferrea 2023 ·Biomedicine & Pharmacotherapy ·Thaís Gomes de Carvalho, Pablo Lara, (unknown), Cícero Flávio Soares Aragão, (unknown), Vinícius Barreto Garcia, (unknown), Timo Schomann, Luiz Alberto Lira Soares, Paulo Marcos da Matta Guedes, Raimundo Fernandes de Araújo Júnior	26
8	Photodynamic Therapy in Combination with the Hepatitis B Core Virus-like Particles (HBc VLPs) to Prime Anticancer Immunity for Colorectal Cancer Treatment 2022 ·Cancers ·Hao Yang, Zili Gu, Zhenfeng Yu, Timo Schomann, (unknown), Julio Aguilar, Peter ten Dijke, Luis J. Cruz	17
9	Rare-Earth-Metal (Nd3+, Ce3+ and Gd3+)-Doped CaF2: Nanoparticles for Multimodal Imaging in Biomedical Applications 2022 ·Pharmaceutics ·Zhenfeng Yu, Yuanyuan He, Timo Schomann, (unknown), Hao Yang, Ernst Suidgeest, Hong Zhang, Christina Eich, Luis J. Cruz	10
10	Extracellular Vesicles from M1-Polarized Macrophages Combined with Hyaluronic Acid and a β-Blocker Potentiate Doxorubicin’s Antitumor Activity by Downregulating Tumor-Associated Macrophages in Breast Cancer 2022 ·Pharmaceutics ·(unknown), Pablo Lara, Luis J. Cruz, Timo Schomann, (unknown), Thaís Gomes de Carvalho, Paulo Marcos da Matta Guedes, Laura B. Creemers, Roman I. Koning, Alan Chan, Raimundo Fernandes de Araújo Júnior	21
11	Achieving Effective Multimodal Imaging with Rare-Earth Ion-Doped CaF2 Nanoparticles 2022 ·Pharmaceutics ·Zhenfeng Yu, Yuanyuan He, Timo Schomann, (unknown), Hao Yang, Ernst Suidgeest, Hong Zhang, Christina Eich, Luis J. Cruz	16
12	Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment 2022 ·Molecular Biomedicine ·Hao Yang, Chih Kit Chung, Zili Gu, Timo Schomann, (unknown), (unknown), Marcel Camps, Peter ten Dijke, Ferry Ossendorp, Luis J. Cruz	34
13	Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticles 2022 ·Biomaterials Advances ·Yuanyuan He, Raimundo Fernandes de Araújo Júnior, (unknown), (unknown), Timo Schomann, Zili Gu, Christina Eich, Luis J. Cruz	16
14	Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer 2022 ·Molecular Therapy — Nucleic Acids ·Iolanda Scognamiglio, (unknown), (unknown), Francesco Palma, (unknown), Cristina Quintavalle, Alessandra Affinito, Giuseppina Roscigno, Silvia Nuzzo, (unknown), Stefania Belli, Guglielmo Thomas, Timo Schomann, Alan Chan, Maria Patrizia Stoppelli, Gerolama Condorelli	44
15	A multimodal molecular imaging approach targeting urokinase plasminogen activator receptor for the diagnosis, resection and surveillance of urothelial cell carcinoma 2021 ·European Journal of Cancer ·(unknown), Geertje van der Horst, Marion M. Deken, Shadhvi S. Bhairosingh, Timo Schomann, (unknown), Maaike H. van der Mark, Luisa Iamele, Hugo de Jonge, Massimo Resnati, Andrew P. Mazar, Rob C.M. Pelger, Gabri van der Pluijm, Peter J.K. Kuppen, Alexander L. Vahrmeijer, Cornelis F.M. Sier	11
16	Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury 2020 ·Cell and Tissue Research ·Timo Schomann, (unknown), Ivo Que, Yuedan Li, Ernst Suidgeest, Luis J. Cruz, Johan H. M. Frijns, Alan Chan, (unknown), Margriet A. Huisman, Laura Mezzanotte	4
17	Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer 2020 ·Materials Science and Engineering C ·(unknown), (unknown), Luis J. Cruz, Timo Schomann, Alan Chan, Thaís Gomes de Carvalho, (unknown), Aurigena Antunes de Araújo, Lioe‐Fee de Geus‐Oei, Raimundo Fernandes de Araújo Júnior	19
18	PLGA-Nanoparticles for Intracellular Delivery of the CRISPR-Complex to Elevate Fetal Globin Expression in Erythroid Cells 2020 ·Biomaterials ·Luis J. Cruz, Thamar van Dijk, (unknown), Tracy Li, Timo Schomann, (unknown), Ryo Kurita, Yukio Nakamura, Frank Grosveld, Sjaak Philipsen, Christina Eich	46
19	Environmentally compatible bioconjugated gold nanoparticles as efficient contrast agents for inflammation-induced cancer imaging 2019 ·Nanoscale Research Letters ·Vinícius Barreto Garcia, Thaís Gomes de Carvalho, Luiz H. S. Gasparotto, (unknown), Aurigena Antunes de Araújo, Gerlane Coelho Bernardo Guerra, Timo Schomann, Luis J. Cruz, Alan Chan, Raimundo Fernandes de Araújo Júnior	5
20	1,8-Cineol inhibits nuclear translocation of NF-κB p65 and NF-κB-dependent transcriptional activity 2013 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Johannes F. W. Greiner, Janine Müller, Marie-Theres Zeuner, Stefan Hauser, Thorsten Seidel, (unknown), (unknown), Timo Schomann, Darius Widera, Holger Sudhoff, Barbara Kaltschmidt, Christian Kaltschmidt	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact